Prevalence of NAFLD in ACS Patients (PADAC)

East Limburg Hospital

Status: Completed

Conditions: ACS - Acute Coronary Syndrome; NAFLD

Treatments: Diagnostic Test: Non-invasive diagnostic testing

Study type: Interventional

Funder types: Other

Identifiers

NCT05378321

PADAC-01

Details and patient eligibility

About

Addressing CVD risk in patients with NAFLD is the aspect of the disease most amenable to medical management and so improving long-term clinical outcomes. Almost no studies have been done concerning the prevalence of NAFLD in CVD patients, most of the conducted studies have been done in already diagnosed NAFLD patients to estimate the risk of CVD development. Currently, there are no data available about the prevalence of NAFLD in CVD, more specifically patients with an acute cardiovascular event (ACE) in Belgium.

Enrollment: 225 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• >18 years
• having acute cardiovascular syndrome
• able to understand Dutch
• able to understand the informed consent

Exclusion criteria

• excessive alcohol abuse
• other liver disease
• secondary causes of steatosis

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

225 participants in 1 patient group

ACS risk gropu

Other group

Description:

Group of patients with an acute-cardiovascular syndrome.

Treatment:

Diagnostic Test: Non-invasive diagnostic testing